) has been revised to $7.65 / share. This is a decrease of 21.05% from the prior estimate of $9.69 dated November 14, 2025. The price target is an average of many targets provided by analysts. The ...

Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and fiscal year ended December 31, 2025. "2025 was ...

Bionano Genomics ((BNGO)) has held its Q3 earnings call. Read on for the main highlights of the call. Bionano Genomics’ recent earnings call painted a picture of robust financial health, underscored ...

SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP) Annual Meeting, held November 11-15, 2025 in Boston, MA. Key ...